Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
According to Baxter's latest financial reports the company's current EPS (TTM) is ยฃ3.86. In 2022 the company made an earnings per share (EPS) of -ยฃ3.64 a decrease over its 2021 EPS that were of ยฃ1.93.
Year | EPS | Change |
---|---|---|
2023 (TTM) | ยฃ4.21 | -215.59% |
2022 | -ยฃ3.64 | -288.67% |
2021 | ยฃ1.93 | 18.52% |
2020 | ยฃ1.63 | 10.2% |
2019 | ยฃ1.48 | -34.45% |
2018 | ยฃ2.25 | 126.52% |
2017 | ยฃ0.99 | -85.45% |
2016 | ยฃ6.83 | 411.9% |
2015 | ยฃ1.33 | -61.48% |
2014 | ยฃ3.47 | 24.32% |
2013 | ยฃ2.79 | -12.32% |
2012 | ยฃ3.18 | 7.93% |
2011 | ยฃ2.95 | 61.57% |
2010 | ยฃ1.82 | -33.52% |
2009 | ยฃ2.74 | 12.69% |
2008 | ยฃ2.43 | 21.89% |
2007 | ยฃ2.00 | 23.26% |
2006 | ยฃ1.62 | 38.71% |
2005 | ยฃ1.17 | 146.03% |
2004 | ยฃ0.47 | -58% |
2003 | ยฃ1.13 | 17.8% |
2002 | ยฃ0.96 | 12.19% |
2001 | ยฃ0.86 | -11.67% |
2000 | ยฃ0.97 | -6.55% |
1999 | ยฃ1.04 | 141.23% |
1998 | ยฃ0.43 | 7.55% |
1997 | ยฃ0.40 | -42.55% |
1996 | ยฃ0.70 |